Compare MediClin AG with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with a 2.95% CAGR growth in Net Sales over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.20
- The company has been able to generate a Return on Equity (avg) of 3.33% signifying low profitability per unit of shareholders funds
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.69%
0%
1.69%
6 Months
21.48%
0%
21.48%
1 Year
23.97%
0%
23.97%
2 Years
41.41%
0%
41.41%
3 Years
13.12%
0%
13.12%
4 Years
6.47%
0%
6.47%
5 Years
-17.73%
0%
-17.73%
MediClin AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
3.11%
EBIT Growth (5y)
48.02%
EBIT to Interest (avg)
1.20
Debt to EBITDA (avg)
0.28
Net Debt to Equity (avg)
-0.05
Sales to Capital Employed (avg)
2.07
Tax Ratio
21.26%
Dividend Payout Ratio
7.65%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.14%
ROE (avg)
3.33%
Valuation key factors
Factor
Value
P/E Ratio
5
Industry P/E
Price to Book Value
0.69
EV to EBIT
2.16
EV to EBITDA
1.22
EV to Capital Employed
0.66
EV to Sales
0.19
PEG Ratio
0.01
Dividend Yield
0.28%
ROCE (Latest)
30.45%
ROE (Latest)
14.25%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
203.10
199.00
2.06%
Operating Profit (PBDIT) excl Other Income
39.70
30.20
31.46%
Interest
5.50
5.60
-1.79%
Exceptional Items
0.00
0.00
Consolidate Net Profit
15.40
10.00
54.00%
Operating Profit Margin (Excl OI)
130.70%
86.10%
4.46%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is 2.06% vs 7.68% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is 54.00% vs 10,100.00% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
748.80
730.10
2.56%
Operating Profit (PBDIT) excl Other Income
90.70
64.00
41.72%
Interest
22.70
22.60
0.44%
Exceptional Items
0.00
0.00
Consolidate Net Profit
24.90
-10.70
332.71%
Operating Profit Margin (Excl OI)
54.00%
-30.20%
8.42%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 2.56% vs 3.60% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 332.71% vs -210.31% in Dec 2023
About MediClin AG 
MediClin AG
Hospital
No Details Available.
Company Coordinates 
No Company Details Available






